KORU (KRMD) Q2 2026 Earnings Call Transcript

KORU Medical Systems held its second quarter earnings conference call on August 5, addressing financial results for the period ending June 30. President and CEO Adam Kalbermatten reported record quarterly revenues of $12 million, reflecting 18% growth compared to the prior year period. The company’s domestic core revenue reached $8 million, up 12% year-over-year, driven by new patient starts and market share gains in the subcutaneous immunoglobulin market. International core revenue total